The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Mastiplan LC, 300mg/20mg (Cefapirin/Prednisolone), intramammary suspension for lactating cows

300, 20 mg/syringe Intramammary suspension

Intervet Ireland LimitedVPA10996/205/001

Main Information

Trade NameMastiplan LC, 300mg/20mg (Cefapirin/Prednisolone), intramammary suspension for lactating cows
Active SubstancesCefapirin
Strength300, 20 mg/syringe
Dosage FormIntramammary suspension
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/205/001

Group Information

ATC CodeQJ51RV01 antibacterials and corticosteroids
Therapeutic ClassAntibacterial


Licence Issued08/06/2007
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back